William Pickering
Stock Analyst at Bernstein
(1.14)
# 3,686
Out of 4,918 analysts
24
Total ratings
40%
Success rate
-8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Initiates: Market Perform | $13 | $15.91 | -18.29% | 1 | Jul 29, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $401.80 | -22.85% | 2 | Jan 7, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $1,110 → $1,070 | $558.87 | +91.46% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $15.93 | +50.66% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $14.71 | +348.67% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $58.14 | +54.80% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $43.03 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $462.13 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $11.49 | +369.97% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $18.83 | +96.49% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $6 | $1.08 | +455.56% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $56.09 | -21.55% | 1 | Mar 21, 2023 |
Sarepta Therapeutics
Jul 29, 2025
Initiates: Market Perform
Price Target: $13
Current: $15.91
Upside: -18.29%
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $401.80
Upside: -22.85%
Regeneron Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $1,110 → $1,070
Current: $558.87
Upside: +91.46%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $15.93
Upside: +50.66%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $14.71
Upside: +348.67%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $58.14
Upside: +54.80%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $43.03
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $462.13
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $11.49
Upside: +369.97%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $18.83
Upside: +96.49%
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.08
Upside: +455.56%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $56.09
Upside: -21.55%